Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEZO-HP: Perindopril vs Zofenopril in Black Hypertensive Patients
NCT04254042Phase 4Completed
- Sponsor
- Yaoundé Central Hospital
- Start
- Oct 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertension (HTN) comparing Perindopril Arm with Zofenopril Arm (2 arms). Primary endpoint: Change in nycthemeral blood pressure profile at 8 weeks. Started Oct 2018; status: completed.
02
Drugs
zofenoprilperindopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04254042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04254042.